Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling

por Kauko, Otto, Laajala, Teemu Daniel, Jumppanen, Mikael, Hintsanen, Petteri, Suni, Veronika, Haapaniemi, Pekka, Corthals, Garry, Aittokallio, Tero, Westermarck, Jukka, Imanishi, Susumu Y.
Publicado en Sci Rep (2015)

Optimized design and analysis of preclinical intervention studies in vivo

por Laajala, Teemu D., Jumppanen, Mikael, Huhtaniemi, Riikka, Fey, Vidal, Kaur, Amanpreet, Knuuttila, Matias, Aho, Eija, Oksala, Riikka, Westermarck, Jukka, Mäkelä, Sari, Poutanen, Matti, Aittokallio, Tero
Publicado en Sci Rep (2016)

Synthesis, Identification, and Structure–Activity Relationship Analysis of GATA4 and NKX2-5 Protein–Protein Interaction Modulators

por Jumppanen, Mikael, Kinnunen, Sini M., Välimäki, Mika J., Talman, Virpi, Auno, Samuli, Bruun, Tanja, Boije af Gennäs, Gustav, Xhaard, Henri, Aumüller, Ingo B., Ruskoaho, Heikki, Yli-Kauhaluoma, Jari
Publicado en J Med Chem (2019)

Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds

por Karhu, S. Tuuli, Välimäki, Mika J., Jumppanen, Mikael, Kinnunen, Sini M., Pohjolainen, Lotta, Leigh, Robert S., Auno, Samuli, Földes, Gábor, Boije af Gennäs, Gustav, Yli-Kauhaluoma, Jari, Ruskoaho, Heikki, Talman, Virpi
Publicado en Arch Toxicol (2018)

Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1

por Kauko, Otto, Imanishi, Susumu Y., Kulesskiy, Evgeny, Yetukuri, Laxman, Laajala, Teemu Daniel, Sharma, Mukund, Pavic, Karolina, Aakula, Anna, Rupp, Christian, Jumppanen, Mikael, Haapaniemi, Pekka, Ruan, Luyao, Yadav, Bhagwan, Suni, Veronika, Varila, Taru, Corthals, Garry L., Reimand, Jüri, Wennerberg, Krister, Aittokallio, Tero, Westermarck, Jukka
Publicado en J Biol Chem (2020)